Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C1519176 (
PSA
)
5,490
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Fifty patients were evaluated for serum total
PSA
(Prostate Specific Antigen), free
PSA
(f-PSA), free/total
PSA
ratio (f/t
PSA
ratio) and TPS(TM) (Tissue
Polypeptide
Specific Antigen). Fifty patients were clinically evaluated and categorized into BPH (benign prostatic hypertrophy) and CaP (carcinoma prostate) with twenty-five in each category before the serological examination. Serum total
PSA
concentration is elevated in 80% of BPH cases while it was elevated in all cases of CaP. With total PSA>10ng/mL, f/t
PSA
ratio was not applicable. For TPS(TM), a cell proliferation marker these values were 32% and 92% respectively. The advanced cases of CaP were reflected by the pronounced elevations of
PSA
and TPS(tM) while f/t
PSA
ratio was much below the cut-off limit (cut-off limit=0.14). The data suggest that whentotal
PSA
concentration <10ng/mL, f/t
PSA
ratio plays a very important role in discriminating BPH and CaP. However, TPS(TM) can be used as a valuable adjunct in diagnosis and follow-up of prostate cancer patients, especially in differentiating benign from malignant cases.
...
PMID:The changing scenario in diagnosing prostate cancer. 2310 51